Vitamin D deficiency has been clearly linked to major chronic diseases associated with oxidative stress, inflammation, and aging, including cardiovascular and neurodegenerative diseases, diabetes, and cancer. In particular, the cardiovascular system appears to be highly sensitive to vitamin D deficiency, as this may result in endothelial dysfunction and vascular defects via multiple mechanisms. Accordingly, recent research developments have led to the proposal that pharmacological interventions targeting either vitamin D deficiency or its key downstream effects, including defective autophagy and abnormal pro-oxidant and pro-inflammatory responses, may be able to limit the onset and severity of major cerebrovascular diseases, such as stroke and cerebrovascular malformations. Here we review the available evidence supporting the role of vitamin D in preventing or limiting the development of these cerebrovascular diseases, which are leading causes of disability and death all over the world.

Vitamin D deficiency and the risk of cerebrovascular disease

Perrelli A.
Co-first
;
Ragni A.
Co-first
;
Retta F.
Co-first
;
Retta S. F.
Last
2020-01-01

Abstract

Vitamin D deficiency has been clearly linked to major chronic diseases associated with oxidative stress, inflammation, and aging, including cardiovascular and neurodegenerative diseases, diabetes, and cancer. In particular, the cardiovascular system appears to be highly sensitive to vitamin D deficiency, as this may result in endothelial dysfunction and vascular defects via multiple mechanisms. Accordingly, recent research developments have led to the proposal that pharmacological interventions targeting either vitamin D deficiency or its key downstream effects, including defective autophagy and abnormal pro-oxidant and pro-inflammatory responses, may be able to limit the onset and severity of major cerebrovascular diseases, such as stroke and cerebrovascular malformations. Here we review the available evidence supporting the role of vitamin D in preventing or limiting the development of these cerebrovascular diseases, which are leading causes of disability and death all over the world.
2020
Inglese
Esperti anonimi
9
4 (pii: E327)
1
22
22
https://www.ncbi.nlm.nih.gov/pubmed/32316584
https://www.mdpi.com/2076-3921/9/4/327
https://www.mdpi.com/2076-3921/9/4/327/htm
Antioxidant and anti-inflammatory defenses; Autophagy; Cerebral cavernous malformation (CCM); Cerebrovascular disease; Endothelial dysfunction; Inflammation; Oxidative stress; Redox homeostasis and signaling; Stroke; Vitamin D
AUSTRALIA
1 – prodotto con file in versione Open Access (allegherò il file al passo 6 - Carica)
7
03-CONTRIBUTO IN RIVISTA::03B-Review in Rivista / Rassegna della Lett. in Riv. / Nota Critica
open
262
info:eu-repo/semantics/article
Kim H.A.; Perrelli A.; Ragni A.; Retta F.; De Silva T.M.; Sobey C.G.; Retta S.F.
File in questo prodotto:
File Dimensione Formato  
2020 Antioxidants - Vitamin D Deficiency and the Risk of Cerebrovascular Disease.pdf

Accesso aperto

Descrizione: Articolo principale
Tipo di file: PDF EDITORIALE
Dimensione 1.69 MB
Formato Adobe PDF
1.69 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1737813
Citazioni
  • ???jsp.display-item.citation.pmc??? 39
  • Scopus 67
  • ???jsp.display-item.citation.isi??? 64
social impact